Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIVAMUSE: Diagnostic Value of Musculoskeletal Ultrasound in Early Psoriatic Arthritis Treated With Apremilast
DRKS00025563Phase 4Not yet recruiting
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of apremilast in psoriatic arthritis (PsA) and enthesitis, sponsored by Universitätsklinikum Freiburg. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
apremilast
03
Conditions
psoriatic arthritis (PsA)enthesitis
Beyond the preview
Go deeper on DRKS00025563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00025563.